Recent Updates
Recently added Catalysts
JNJ

Johnson & Johnson to Participate in 38th Annual JP Morgan Health Care Conference Johnson & Johnson (NYSE: JNJ) will participate in the 38th Annual JP Morgan Health Care Conference on Monday, January 13, at the Westin St. Francis...

Key Takeaway: NEW BRUNSWICK, N.J. , Dec. 19, 2019 /PRNewswire/ -- Johnson & Johnson (NYSE: JNJ ) will participate in the 38 th Annual JP Morgan Health Care Conference on Monday, January 13 , at the Westin St. Francis in San Francisco. Ashley McEvoy , Executive Vice President, Worldwide Chairma

BiopharmaWatch Analysis

From our catalyst data and publicly available data · not financial advice
Best trade, last catalyst
+34%
120-day peak, hindsight
Typical move
1.6%
average across 15 past catalysts
Lead asset
Canagliflozin
Phase 3 · Diabetes Mellitus, Type 2

Full Press Release Details

NEW BRUNSWICK, N.J. , Dec. 19, 2019 /PRNewswire/ -- Johnson & Johnson (NYSE: JNJ ) will participate in the 38 th Annual JP Morgan Health Care Conference on Monday, January 13 , at the Westin St. Francis in San Francisco. Ashley McEvoy , Executive Vice President, Worldwide Chairman, Medical Devices and Jennifer Taubert , Executive Vice President, Worldwide Chairman, Pharmaceuticals will represent the Company in a session scheduled at 2:30 p.m. (Pacific Time) / 5:30 p.m. (Eastern Time) . A subsequent Question & Answer session is scheduled for 3:00 p.m. (Pacific Time) / 6:00 p.m. (Eastern Time) .
This webcast will be available to investors and other interested parties by accessing the Johnson & Johnson website at www.investor.jnj.com .
A webcast replay will be available approximately two hours after the live webcast.
Last updated: Dec 19, 2019